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Abstract  1"
Three-dimensional culture models, such as cell spheroids, are widely used in basic and translational 2"
research. Since handling a high number of cell spheroids is more complex and time consuming than 3"
handling monolayer cultures, we exploited laser ablation and replica molding to fabricate 4"
polydimethylsiloxane (PDMS) multi-well chips for the generation and culture of multiple cell 5"
spheroids. Articular chondrocytes (ACs) were used to validate the multi-well PDMS chips. Multi-6"
well spheroids were comparable or superior to standard spheroids in terms of chondrogenic 7"
differentiation. Moreover, the use of multi-well chips significantly reduced the operation time for 8"
cell seeding and medium refresh.  9"
Using a similar approach, clinical-grade fibrin was used to generate implantable multi-well 10"
constructs, allowing differential cell seeding in the construct structure and in the wells. Multi-well 11"
fibrin constructs with high cell density regions were compared with constructs where ACs were 12"
homogeneously distributed. Expression of chondrogenic genes was increased after 7 days in vitro in 13"
both types of constructs, with multi-well constructs showing higher SOX9 and ACAN levels than 14"
standard constructs. Through differential cell staining, we demonstrated that high cell density 15"
regions can be precisely generated in multi-well constructs and that they are still detectable after 5 16"
weeks in vivo.  17"
In conclusion, multi-well chips for the generation and culture of multiple cell spheroids can be 18"
fabricated by low-cost rapid prototyping techniques. Furthermore, these techniques can be used to 19"
generate implantable constructs with defined architecture and spatially controlled cell distribution, 20"
allowing the in vitro and in vivo investigation of cell interactions in a 3D environment. 21"
 22"
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Introduction 1"
Three-dimensional (3D) cultures are widely used as in vitro models for cell culture. Compared with 2"
monolayer cultures, 3D models better mimic the in vivo tissue features, thus providing a 3"
physiologically relevant environment (Abbott 2003). Among different types of 3D models 4"
developed in the last years, multiple cell aggregates or spheroids have been widely used in tumor 5"
(Burdett et al. 2010) and tissue engineering (Fennema et al. 2013) research areas. The screening of 6"
multiple drugs or culture conditions through 3D cell spheroids requires a relevant number of 7"
experimental replicates with cells from different donors, thus making the use of this 3D model more 8"
complex and time-consuming compared to conventional monolayer cultures. 3D spheroids, 9"
whereby specific extracellular matrix is produced by aggregated cells, also represent the living 10"
“building blocks” in organ printing, which aims at the layer-by-layer biofabrication of 3D 11"
functional tissues and organs (Boland et al. 2003; Jakab et al. 2004; Mironov et al. 2009). 12"
The need to generate cell spheroids in a high throughput fashion for cancer research and for basic 13"
and translational tissue engineering studies has encouraged the development of multi-well devices 14"
as an alternative to standard methods for the formation and culture of multiple 3D cell spheroids 15"
(Babur et al. 2013; de Ridder et al. 2000; Moreira Teixeira et al. 2012; Ratnayaka et al. 2013). 16"
Indeed, these devices provide a relevant tool to implement 3D spheroid models, reducing the time 17"
required for routine operations and minimizing differences between experimental replicates. 18"
Rapid prototyping techniques represent an exceptional tool to generate easy-handling platforms for 19"
3D cell culture. However, existing lithography-based approaches are often expensive and time 20"
consuming (Whitesides et al. 2001). Indeed, current approaches based on lithographic fabrication 21"
require cleanroom facilities where any minor change in the design involves increasing costs related 22"
to the fabrication process. Laser fabrication techniques offer an alternative to lithography-based 23"
approaches for rapid prototyping (Becker and Gartner 2008) and have been recently exploited for 24"
the fabrication of micro-wells in order to minimize fabrication complexity (Napolitano et al. 2007; 25"
Piraino et al. 2012; Selimovic et al. 2011). 26"
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Another key element for developing innovative 3D models is the possibility of generating scaffolds 1"
with a controlled micro- and/or macro-scale architecture , directing cell distribution and/or cell 2"
orientation by topographical cues (Bae et al. 2014; Gerberich and Bhatia 2013). Implantable multi-3"
well scaffolds have recently been proposed for the in vivo evaluation of the influence of different 4"
extracellular matrix components on the differentiation of cells seeded within the wells (Higuera et 5"
al. 2013), demonstrating the great potentiality of this approach. 6"
In this study we exploited laser ablation and replica molding to fabricate multi-well 7"
polydimethylsiloxane (PDMS) chips for the culture of multiple cell spheroids, using human 8"
articular chondrocytes (ACs) for their validation. ACs are widely investigated in the field of 9"
cartilage tissue engineering. Their re-differentiation, necessary to re-acquire their original 10"
phenotype after in vitro expansion (Giannoni and Cancedda 2006; Giannoni et al. 2005; Schulze-11"
Tanzil 2009), is traditionally performed in 3D conditions (Bernstein et al. 2009; Dehne et al. 2010; 12"
Jakob et al. 2001; Zhang et al. 2004), indicating that this cell population is a suitable cell source for 13"
the validation of platforms for 3D spheroid formation and culture.  14"
The same rapid prototyping techniques were used to biofabricate implantable fibrin multi-well 15"
constructs, allowing differential cell seeding into the construct structure and into the wells. We used 16"
a clinical-grade fibrin glue (Ahmed et al. 2008; Ahmed and Hincke 2010; Colombini et al. 2014a; 17"
Scotti et al. 2010) to validate our biofabrication process and through differential cell staining we 18"
verified the feasibility of precise cell seeding in different regions of the multi-well construct. As a 19"
proof of concept, we biofabricated fibrin constructs whereby human ACs were homogeneously 20"
dispersed or where different cell density regions were generated. Then, we evaluated cell behavior 21"
in standard and multi-well fibrin constructs after 1 and 7 days of in vitro culture and after 5 weeks 22"
of subcutaneous implantation in nude mice. 23"
 24"
Materials and Methods 25"
Cell isolation and expansion 26"
5 
Samples of articular cartilage were harvested from patients affected by osteoarthritis undergoing 1"
total hip replacement (5 males and 5 females, mean age 64±8 years), with patients’ informed 2"
written consent and with the approval of the Institutional Review Board. ACs were isolated from 3"
cartilage by enzymatic digestion using 0.15% type II collagenase (Worthington Biochemical Co) 4"
for 22 h at 37°C, according to a previously established protocol (Lagana et al. 2014; Lopa et al. 5"
2013). The cells were plated at a density of 104 cells/cm2 and cultured in expansion medium. 6"
Expansion medium was composed as follows: High Glucose Dulbecco’s Modified Eagle’s Medium 7"
(HG-DMEM, Gibco) supplemented with 10% Fetal Bovine Serum (FBS, Lonza), 1% HEPES 8"
(Gibco), 1% Sodium pyruvate (Gibco), 1% Penicillin/Streptomycin/Glutamine (Gibco), 1 ng/mL 9"
Transforming Growth Factor ß-1 (TGF-ß1, Peprotech) and 5 ng/mL Fibroblast Growth Factor 2 10"
(FGF-2, Peprotech). At subconfluence, cells were detached by 0.05% trypsin/0.53 mM EDTA 11"
(Gibco) and plated at 5×103 cells/cm2 for further expansion. At passage 2, cells were frozen and 12"
stored in liquid nitrogen. When needed, cells were thawed and expanded for one additional passage. 13"
To limit the expansion phase required to obtain a suitable number of cells, cells from different 14"
donors were pooled together to perform the experiments. 15"
"16"
Multi-well PDMS chips 17"
Fabrication of PMMA templates and multi-well PDMS chips 18"
Drawings of PMMA master templates were made by AutoCAD® software (©Autodesk, Inc.) and 19"
processed by Corel® DRAWTM software (©Corel Corporation, 2002). Master templates were 20"
obtained by carbon dioxide (CO2) laser ablation of a polymethylmethacrylate (PMMA) substrate 21"
(Fig. 1a, step I) in single hole drilling mode, as previously described (Piraino et al. 2012; Selimovic 22"
et al. 2011). The laser power was set at 22.5 W, the write speed at 0.08 mm/s, and z = 17.2 mm 23"
(VLS2.30, VersaLASER). Substrate removal through ablation produced features with a Gaussian-24"
profile. A PDMS mixture (Sylgard® 184, Dow Corning) was prepared at a 10:1 ratio 25"
(prepolymer/curing agent), degassed, poured on the PMMA master template, and baked at 70°C for 26"
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2h (Fig. 1a, step II). Once polymerized, the PDMS was carefully peeled off the PMMA master 1"
template and cleaned with 70% EtOH. After rinsing with ddH2O, PDMS multi-well chips were 2"
sterilized by autoclave. 3"
Two different configurations of PDMS multi-well chips were designed to host 19 wells in a single 4"
chip. Features of the two multi-well chip configurations, named Chip A and Chip B, and their 3D 5"
renderings are reported respectively in Fig. 1b and 1c.  6"
Cell spheroid formation 7"
Sterile PDMS chips were placed in a 12 well multiwell plate and each PDMS chip was seeded with 8"
a total number of 2.85x106 cells by pipetting 1.5x105 cells in each single well (Fig. 1a, step III). The 9"
12 well multiwell plate was then centrifuged for 5 min at 230g to favor spheroid formation. After 2 10"
h, 2.85 mL of chondrogenic medium were gently added to each well (Fig. 1a, step IV). Control 11"
(Ctrl) spheroids were prepared in 1.5 ml screw-cap conical tubes. Briefly, 1.5x105 cells were 12"
suspended in 150 µL of chondrogenic medium, transferred to a tube, and centrifuged for 5 min at 13"
230g. Chondrogenic medium was composed as follows: HG-DMEM supplemented with 0.029 14"
mg/ml L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, 10 mM Hepes, 1 mM sodium 15"
pyruvate, 1.25 mg/ml Human Serum Albumin (HSA, Sigma-Aldrich), 1% ITS+1 (containing 1.0 16"
mg/ml insulin from bovine pancreas, 0.55 mg/ml human transferrin, 0.5 µg/ml sodium selenite, 50 17"
mg/ml bovine serum albumin and 470 µg/ml linoleic acid, Sigma-Aldrich), 0.1 µM dexamethasone, 18"
0.1 mM L-ascorbic acid-2-phosphate and 10 ng/ml TGF-β1. Samples were cultured for 21 days 19"
(37°C, 5% CO2). Medium was replaced twice per week. 20"
Measurement of operation time for cell seeding and medium refresh 21"
For spheroid culture in standard tubes and in multi-well PDMS chips, we measured the operation 22"
time required to perform cell seeding and medium refresh. Independent measures were obtained 23"
testing 3 operators with different skill levels in cell culture techniques. 24"
Spheroid analysis 25"
Evaluation of spheroid area 26"
7 
After 7, 14, and 21 days of culture in chondrogenic medium, spheroids in the multi-well chips were 1"
photographed to monitor the size variation. Spheroid area was determined by image analysis using 2"
ImageJ software.  3"
Quantification of metabolic activity and DNA content 4"
After 21 days of culture in chondrogenic medium, cell metabolic activity was evaluated by Alamar 5"
Blue assay. Briefly, spheroids were randomly harvested from different PDMS chips and from the 6"
tubes (control group), transferred to a 96 well multiwell plate, and incubated with 100 µL HG-7"
DMEM supplemented with 10% Alamar Blue for 4 h at 37°C. After incubation, the supernatant was 8"
harvested and fluorescence was measured (540 nm-580 nm) using a Victor X3 Plate Reader (Perkin 9"
Elmer). The same spheroids were lysed for DNA quantification. After washing with Phosphate 10"
Buffered Saline (PBS), spheroids were digested (16 h, 60°C) in 500 µl of PBE buffer (100 mM 11"
Na2HPO4, 10 mM NaEDTA, pH 6.8) containing 1.75 mg/ml L-cystein (Sigma-Aldrich) and 14.2 12"
U/ml papain (Worthington). DNA quantification was performed by CyQUANT Kit (Invitrogen), 13"
according to the manufacturer’s instructions. 14"
Histological and immunohistochemical analysis 15"
For histological analysis, chondrocyte spheroids cultured for 21 days were fixed for 24 h in 10% 16"
neutral buffered formalin, embedded in paraffin and sectioned at 3 µm. Sections were stained with 17"
alcian blue (pH 2.5, Sigma-Aldrich) to detect glycosaminoglycans (GAGs). For 18"
immunohistochemistry, sections were deparaffinized, rehydrated, and treated with 3% hydrogen 19"
peroxide in distilled water for 15 min. Mouse monoclonal anti-Collagen II antibody (SPM239, 20"
ab54236,Abcam) was applied at room temperature for 1 h. The sections were labeled by the avidin-21"
biotin-peroxidase (ABC) procedure (Hsu et al. 1981) with a commercial immunoperoxidase kit 22"
(Vectastain Standard Elite; Vector Laboratories). The immunohistochemical reaction was 23"
developed with 3.3′ diaminobenzidine (DAB) for 5 min and sections were counterstained for 2 min 24"
with Mayer's hematoxylin. 25"
 26"
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Implantable multi-well fibrin constructs 1"
Fabrication of PMMA master templates and PDMS counter-molds 2"
PMMA master templates and the corresponding PDMS counter-molds were fabricated by CO2 laser 3"
ablation (Fig. 2a, step I) and replica molding (Fig. 2a, step II), as previously described for the 4"
fabrication of multi-well PDMS chips.  5"
Three different configurations of PDMS molds were designed to biofabricate fibrin constructs with 6"
multi-well bottom layers containing 19, 10, or 7 wells (Fig. 2b). Features of the three different 7"
PDMS mold configurations, named Mold X, Mold Y, and Mold Z, and their 3D renderings are 8"
reported respectively in Fig. 2b and 2c. Immediately prior to use, PDMS molds were plasma treated 9"
(Harrick Plasma Instruments, USA) for 8 minutes to reduce surface hydrophobicity. 10"
Biofabrication of multi-well fibrin constructs 11"
The two-component fibrin sealant Tisseel® (Baxter Biosurgery) was used to generate the fibrin 12"
constructs. The fibrinogen component contained 91 mg/mL human fibrinogen and 3000 KIU/mL 13"
aprotinin solution. The thrombin component was diluted to 5 U/mL in 40 mM of CaCl2 at pH 7.0. 14"
Initially, fibrin constructs with three different configurations of the multi-well bottom layer were 15"
prepared according to the protocol depicted in Fig. 2a: (X) 19 wells, Øwell 1 mm, hwell 1.5 mm; (Y) 16"
10 wells, Øwell 1.5 mm, hwell 1.5 mm; (Z) 7 wells, Øwell 2 mm, hwell 1.5 mm. For each construct, 17"
1.15x106 cells were suspended in fibrinogen and thrombin mixed at a 1:1 ratio (cell density 18"
15.4x106 cells/mL) and poured into the PDMS molds until polymerization (1 h, 37°C, Fig. 2a, step 19"
III). The bottom layer was then gently removed from the PDMS mold and transferred into a 12 well 20"
multiwell plate. Custom made PDMS rings (Øout 10 mm, Øin 8 mm, h 3 mm) were placed around 21"
the bottom layers. Then, different cell numbers were seeded in each well, depending on the 22"
construct configuration (Fig. 2a, step IV): (X) 1x105 cells in Øwell 1 mm; (Y) 2x105 cells in Øwell 1.5 23"
mm; (Z) 4x105 cells in Øwell 2 mm. After 15 minutes, a fibrin top layer (Ø 8 mm, h 1 mm) was 24"
generated by suspending 8.5x105 cells with fibrinogen and thrombin mixed at a 1:1 ratio (cell 25"
density 15.4x106 cells/mL) and pouring the mixture over the multi-well bottom layer (Fig. 2a, step 26"
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V). In this phase, the PDMS ring was used to match the bottom layer shape and to avoid fibrin 1"
leaking. After polymerization, the PDMS ring was removed and constructs were cultured in 3 mL 2"
chondrogenic medium (Fig. 2a, step VI). After selecting the best bottom layer configuration based 3"
on the reproducibility of construct fabrication and cell seeding into the wells, we compared the 4"
multi-well fibrin constructs (10 wells, Øwell 1.5 mm, hwell 1.5 mm, 2x105 cells/well) with a similar 5"
construct without wells. Both types of fibrin constructs (Ø 8 mm, h 3 mm) were seeded with a total 6"
number of 4x106 cells. Bottom and top layer of the multi-well fibrin constructs were prepared as 7"
aforementioned. To seed the wells of the constructs, a cell suspension with a density of 108 cells/mL 8"
was prepared. In each well, we added 2 µL of solution, corresponding to 2x105 cells. To prepare 9"
standard fibrin constructs without wells, 4x106 cells were suspended in fibrinogen and thrombin 10"
mixed at a 1:1 ratio (cell density 26.7x106 cells/mL). The mixture was poured into the custom made 11"
PDMS rings and let polymerize for 1 h at 37oC. After polymerization, all constructs were cultured 12"
in 3 mL chondrogenic medium. 13"
Fibrin construct analysis 14"
Evaluation of multi-well structure and cell distribution 15"
The macroscopic features of the different bottom layers were evaluated by stereomicroscope 16"
(Olympus SXZ10). Cell distribution into the construct and feasibility of cell seeding into the wells 17"
were evaluated by fluorescence microscopy (Olympus IX71) using green- or red- cells stained 18"
either with the green fluorescent dye Vybrant DiO or with the red fluorescent dye Vybrant CM-Dil 19"
(both from Invitrogen) according to the manufacturer’s instructions. Briefly, after trypsinization 20"
cells were suspended at a density of 1x106 cells/mL in serum-free culture medium. Vybrant DiO or 21"
Vybrant CM-Dil was added to the cell suspension (5 µL/mL). Cells were incubated for 10 min at 22"
37°C and then centrifuged (350g, 5 min). The supernatant was removed and the cells were washed 23"
twice in expansion medium prior to use. 24"
Histological analysis 25"
10 
After 7 days of in vitro culture, fibrin constructs cultured for 7 days were fixed for 24 h in 10% 1"
neutral buffered formalin, embedded in paraffin and sectioned at 3 µm. For morphological 2"
evaluation of fibrin glue constructs, sections were stained with hematoxylin and eosin (HE). 3"
Quantification of DNA and GAGs content 4"
After 7 days of in vitro culture, fibrin constructs were digested, as previously described for 5"
chondrocyte spheroids. DNA quantification was performed by CyQUANT Kit." The amount of 6"
GAGs was spectrophotometrically measured using 16 mg/mL dimethylmethylene blue (Sigma-7"
Aldrich), with chondroitin sulphate as standard (absorbance 525 nm) (Lopa et al. 2014). GAGs 8"
content was normalized to the DNA content and expressed as µg GAGs/µg DNA. 9"
Gene expression analysis 10"
After 1 and 7 days of in vitro culture, fibrin constructs were harvested and stored in liquid nitrogen 11"
for RNA isolation and gene expression analysis. Total RNA was purified using RNeasy Mini kit 12"
(Qiagen) following sample disruption with TissueRuptor (Qiagen). RNA was quantified using a 13"
spectrophotometer (Nanodrop, Thermo Scientific) and reverse-transcribed to cDNA using iScript 14"
cDNA Synthesis Kit (Bio-Rad Laboratories). Gene expression was evaluated by real time PCR 15"
(StepOne Plus, Life Technologies). 40 ng of cDNA were incubated with a PCR mixture including 16"
TaqMan® Universal PCR Master Mix and TaqMan® Assays-on-Demand™ Gene expression probes 17"
(Life Technologies) using the following assays: glyceraldehyde-3-phosphate dehydrogenase 18"
(GAPDH, Hs99999905_m1), SRY (Sex determining region Y)-box9 (SOX9, Hs00165814_m1), 19"
collagen type II alpha I (COL2A1, Hs00264051_m1), aggrecan (ACAN, Hs00153936_m1), and 20"
cartilage oligomeric matrix protein (COMP, Hs00164359_m1) The expression of the analyzed 21"
markers was normalized to GAPDH using the delta Ct method.  22"
Subcutaneous implantation of fibrin constructs in nude mice  23"
Fibrin constructs without or with wells were seeded with green- and red-stained cells and 24"
subcutaneously implanted in nude mice. The in vivo study was approved by the Mario Negri 25"
Institute for Pharmacological Research (IRFMN) Animal Care and Use Committee (IACUC). 26"
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Animals and their care were handled in compliance with institutional guidelines as defined in 1"
national (Law 116/92, Authorization n.19/2008-A issued March 6, 2008, Italian Ministry of Health) 2"
and international laws and policies (EEC Council Directive 86/609, OJ L 358. 1, December 12, 3"
1987; Standards for the Care and Use of Laboratory Animals - UCLA, U.S. National Research 4"
Council, Statement of Compliance A5023-01, November 6, 1998).  5"
Three 6-week-old female athymic mice were obtained from Harlan® and maintained in the Animal 6"
Care Facilities of the IRFMN, under specific pathogen-free conditions with food and water 7"
provided ad libitum. Animals were anesthetized by intraperitoneal injection of ketamine chloride 8"
(80 mg/kg, Imalgene, Merial) and medetomidine hydrochloride (1 mg/kg, Domitor, Pfizer). 9"
Surgical procedures were performed in sterile conditions under a laminar flow hood. Four 10"
subcutaneous pockets were created on the dorsum of each mouse by blunt dissection through cranial 11"
and caudal skin incisions. One fibrin construct was inserted in each pocket, then the skin was 12"
sutured with #4-0 Monocryl thread (Ethicon). After 5 weeks, mice were euthanized by CO2 13"
inhalation and constructs were explanted. 14"
Explant analysis 15"
Evaluation of cell distribution 16"
After 5 weeks in vivo, the distribution of green- and red- stained cells in the explants was evaluated 17"
by fluorescent microscopy (Olympus IX71). 18"
Quantification of GAGs content 19"
Fibrin constructs cultured in vitro for 7 days were analyzed before and after in vivo subcutaneous 20"
implantation for 5 weeks. Samples were digested in PBE buffer and GAGs were quantified by 21"
dimethylmethylene blue assay, as aforementioned. GAGs content was normalized to the construct 22"
wet weight (mg). 23"
 24"
Statistical analysis 25"
12 
All data are presented as mean±SD. Kolmogorov-Smirnov test was used to assess the normal data 1"
distribution (GraphPad Prism version 5.00 for Windows, GraphPad Software). For spheroid 2"
analysis, comparison among the three different experimental groups (control spheroids, spheroids in 3"
chip A, spheroids in chip B) was performed by One-Way ANOVA with Dunnett’s post hoc-test. 4"
Mann-Whitney test (unpaired data) for non-normally distributed data was performed to compare 5"
different types of fibrin constructs at the same time point (i.e. w/ wells 1d vs. w/o wells 1d) and to 6"
compare the same type of fibrin construct at different time points (i.e. w/ wells 1d vs. w/ wells 7d). 7"
 8"
Results 9"
Multi-well PDMS chips support the generation and culture of chondrocyte spheroids 10"
Multi-well chips were generated by PDMS replica molding on a laser-ablated PMMA master 11"
templates. Optical images of the fabricated multi-well PDMS chips in figure 1d show the fidelity of 12"
the multi-well arrays to the original design. As expected, the side view of the PDMS chips section 13"
revealed the conical shape of the wells (Fig. 1d, bottom panel).  14"
Articular chondrocytes were used to validate the multi-well PDMS chips as devices for the 15"
formation and culture of 3D cell spheroids. The PDMS chips were designed to fit the wells of a 12 16"
multiplate, allowing the simultaneous culture of several spheroids in different experimental 17"
conditions in the same plate, as shown in figure 3a, where PDMS chips immediately after cell 18"
seeding are depicted. The use of these devices significantly reduced the time required for cell 19"
seeding and medium refresh operations compared to standard spheroid culture, representing a 20"
technical amelioration in terms of work efficiency (Fig. 3b,c). The PDMS chips, thanks to the 21"
transparency of the material, also allowed us to monitor the samples through microscopy over the 22"
entire period of culture and to measure basic parameters, such as spheroid area. As shown in figure 23"
3d, cell aggregates started to form already 24 hours after cell seeding and, after 21 days of culture, 24"
spheroids were well-formed in both PDMS chips. Spheroid area increased from 7 to 21 days of 25"
chondrogenic culture due to matrix deposition (Fig. 3e). At the end of culture, we compared the 26"
13 
metabolic activity of spheroids cultured in standard tubes (Ctrl) and in PDMS chips. No significant 1"
difference in metabolic activity was observed among the experimental groups (Fig. 3f). In the same 2"
way, the DNA content and the metabolic activity normalized on DNA of spheroids cultured in 3"
standard tubes and in PDMS chips did not differ, showing that spheroids cultured in PDMS chips 4"
were at least as viable and active standard spheroids (Fig. 3g,h). Histological evaluation revealed 5"
that GAGs deposition, which is a key marker of chondrogenic differentiation, was comparable in 6"
Ctrl spheroids and in spheroids cultured in multi-well PDMS chips (Fig. 3i). Lacunar structures, 7"
similar to those found in native hyaline cartilage, were observed in all the experimental groups. 8"
Analysis of type II collagen deposition by immunohistochemistry displayed a more intense staining 9"
in spheroids cultured in PDMS chips compared to standard spheroids, indicating the production of 10"
highly specialized extracellular matrix in these samples (Fig. 3j).  11"
 12"
Implantable multi-well fibrin constructs with high cell density regions support the 3D culture 13"
and re-differentiation of articular chondrocytes 14"
Multi-well fibrin glue constructs were prepared according to the scheme in Fig. 1b. The simplicity 15"
of the biofabrication process allowed us to prepare 65 multi-well constructs in a single experimental 16"
run. PMMA master templates and PDMS molds with the three different configurations (X, Y, Z) 17"
were used to generate the corresponding bottom layers (Fig. 4a). We noticed that the configuration 18"
with 10 wells (Øwell 1.5 mm) was the easiest to fabricate and handle. Indeed, the configuration with 19"
larger wells (Øwell 2 mm) had a very thin outer border that did not allow for the easy removal of the 20"
construct from the PDMS mold. The peripheral border of these constructs tended to break during 21"
this operation (Fig. 4a, upper row), resulting in leaking of the seeded cells into the adjacent wells. 22"
On the other hand, the configuration with smaller wells (Øwell 1 mm) was quite easy to manipulate 23"
since stiffer, but small imperfections in the fibrin bottom layer resulted in a dramatic reduction of 24"
the volume of the wells (Fig. 4a, upper row), which challenged the reproducibility of cell seeding. 25"
Cell embedding in the bottom layer resulted in a homogeneous cell distribution (Fig. 4b, upper row, 26"
14 
green-stained cells) and cell seeding in the multi-wells proved also to be effective (Fig. 4b, middle 1"
and lower row). Based on the aforementioned considerations about simplicity and reproducibility of 2"
fabrication, we selected the configuration (Y) with 10 wells (Øwell 1.5 mm, hwell 1.5 mm) for the 3"
prosecution of the study. The central section of the bottom layer shows the cell deposition on the 4"
bottom side of each well (Fig. 4c), demonstrating that red-stained cells were confined into the wells 5"
and that we were able to generate regions with different cell density in a single construct. The multi-6"
well constructs were completed by adding the top layer, as shown in figure 4d, where the multi-well 7"
array in the finalized scaffold can be observed.  8"
In figure 5a, macroscopic pictures of fibrin constructs without and with wells show that the pattern 9"
of multi-wells was still visible under the top layer (right image). In fibrin constructs without wells, 10"
cells were homogeneously distributed throughout the entire scaffold (Fig. 5b,c, left image), whereas 11"
in multi-well constructs single wells were clearly visible and hematoxylin/eosin staining showed 12"
that a cell multi-layer was present in the wells (Fig. 5b,c, right image), demonstrating once again 13"
that different cell density areas were generated in the construct. As revealed by histological 14"
analysis, poor matrix deposition and construct remodeling occurred after 7 days of in vitro culture 15"
(Fig. 5c), probably due to the high concentration of fibrinogen used in our constructs as well as to 16"
the short period of in vitro culture. 17"
After 7 days of culture in chondrogenic medium, the same number of cells was found in fibrin 18"
constructs without and with wells (Fig. 5d) and no significant difference in terms of GAGs content 19"
per cell between the two types of fibrin constructs was observed (Fig. 5e). Gene expression analysis 20"
performed after 1 and 7 days of culture in chondrogenic medium revealed that both types of fibrin 21"
constructs well supported chondrocyte re-differentiation. Indeed, we observed that levels of 22"
chondrogenic markers such as SOX9, COL2A1, ACAN, and COMP increased from day 1 to day 7, 23"
with significant differences between time points for all the analyzed markers with the exception of 24"
SOX9 (Fig. 5f-i). Higher transcriptional levels of all the tested markers were measured in ACs 25"
15 
cultured in fibrin constructs with high cell density regions for 7 days, albeit increases with respect 1"
to constructs without wells were not significantly different (Fig. 5f-i). 2"
Finally, we evaluated the in vivo behavior of ACs in fibrin constructs without or with wells through 3"
subcutaneous implantation in nude mice. After 5 weeks of implantation, construct size was 4"
dramatically reduced. The pictures reported in Fig. 6a represent the same constructs imaged before 5"
and after in vivo implantation with the same microscope magnification, clearly showing the 6"
diameter reduction from 8 mm to 1.5-2 mm. Surprisingly, despite the reduction in construct size, 7"
the multi-well structure was maintained, as shown in the post-implantation pictures where the high 8"
cell density areas corresponding to the wells are still visible. GAGs content was evaluated in the 9"
fibrin constructs cultured in vitro for 7 days (pre-implantation) and in the explants harvested after 5 10"
weeks of subcutaneous implantation (post-implantation). The content of GAGs normalized on 11"
construct wet weight was found to be significantly increased in both types of fibrin constructs after 12"
5 weeks in vivo, with no significant differences between the two types of fibrin constructs at any 13"
time point (Fig. 6b). 14"
 15"
Discussion 16"
The primary purpose of this study was to generate multi-well PDMS chips supporting the formation 17"
and culture of cell spheroids and to biofabricate a multi-well fibrin construct through low-cost and 18"
easily accessible rapid prototyping techniques. 19"
Compared to standard protocols, the use of the PDMS multi-well chips significantly reduced the 20"
operation time for cell seeding and medium refresh, which are highly time-consuming factors when 21"
preparing several experimental replicates and working with many experimental groups. The 22"
possibility to culture simultaneously a maximum of 228 cell spheroids in a single 12 well multiwell 23"
plate also reduced the space required for the culture of such a high number of samples in the CO2 24"
incubator. Furthermore, the optical transparency of the PDMS chips allowed us to monitor the 25"
16 
process of spheroid formation and the changes in dimension and shape occurring during culture. 1"
The high hydrophobicity of PDMS (Berthier et al. 2012), related to the low cell adhesion on this 2"
material, led to the formation of well-defined chondrocyte spheroids in both the tested 3"
configurations. The comparison between spheroids generated and cultured in PDMS chips with 4"
spheroids in polypropylene tubes did not show any significant difference in terms of cell 5"
proliferation and metabolic activity. On the contrary, while deposition of GAGs was similar in the 6"
different experimental groups, type-II collagen was more present in spheroids cultured in the PDMS 7"
chips compared to standard spheroids. These results indicate that the multi-well devices were able 8"
to support very well both cell viability and chondrogenic differentiation, thus representing an 9"
appealing option for 3D cell culture. A similar approach has been used in a very recent study to 10"
produce and culture chondrocyte micro-pellets (166 cells/pellet) by Babur and co-workers (Babur et 11"
al. 2013). In their study, the PDMS insert surface had to be chemically modified to avoid cell 12"
spreading all over the well. By contrast, in our devices the higher ratio between the number of 13"
plated cells and the surface available for cell growth overcame the need for any chemical surface 14"
treatment, since centrifugation was sufficient to trigger spheroid formation in the wells. Rapid 15"
prototyping of PDMS devices hold great potential for studies requiring the indirect co-culture of 16"
different cell types, as previously reported for hepatocytes and Kupffer cells (Zinchenko and Coger 17"
2005). In our system, the possibility to precisely seed each well with a specific cell population, 18"
together with the easiness of spheroid harvesting from selected wells, allows to evaluate the effect 19"
of paracrine factors in each cell type, representing a complementary alternative to the trans-well 20"
system where cells are traditionally cultured in monolayer. A major limitation in the use of the 21"
presented multi-well devices may be represented by the high hydrophobicity and porosity of PDMS 22"
which may cause the nonspecific absorption of small molecules and hence bias the biological 23"
outcomes in cell culture applications (Toepke and Beebe 2006). In our multi-well system, to 24"
maintain stable cell culture conditions and to reduce the effects of nonspecific absorption into 25"
PDMS, we performed systematic replacement of culture medium. Indeed, we did not observe any 26"
17 
negative effect on the re-differentiation of ACs cultured in multi-well PDMS chips compared to 1"
spheroids cultured in standard polypropylene tubes. However, since in the last years a number of 2"
surface treatments have been developed to prevent nonspecific absorption of molecules, such as sol-3"
gel chemistry (Gomez-Sjoberg et al. 2010) or pre-treatment with n-dodecyl-β-D-maltoside (Huang 4"
et al. 2005), or polyethylene glycol and N-acetyl-L-cysteine (Harris et al. 2011) we envision in the 5"
future to pre-treat our PDMS devices to minimize possible bias in studies evaluating the paracrine 6"
interaction between multiple cell types. Besides applications in basic research investigating the 7"
mutual influence between different cell types, multi-well PDMS chips can be used to produce a 8"
high number of mini-tissue spheroids, which represent the building blocks in organ printing 9"
approaches (Boland et al. 2003; Jakab et al. 2004; Mironov et al. 2009). Indeed, we found that 10"
spheroids were viable and metabolically active after a relatively long culture period and histological 11"
evaluation showed that cells were able to produce specific extracellular matrix. Finally, considering 12"
the field of cartilage tissue engineering, the low-cost multi-well PDMS chips described here could 13"
be exploited to generate a high number of autologous 3D chondral spheroids to be used in the 14"
treatment of chondral defects, as proposed by a recent clinical trial (http://clinicaltrials.gov/, 15"
NCT01222559).  16"
Here, to generate cell spheroids we exploited low-cost rapid prototyping techniques to fabricate 17"
multi-well PDMS chips and we took advantage of centrifugal force to promote cell assembly into 18"
3D spheroids. More complex systems can also be implemented. For example, cell spheroids can be 19"
generated within microfluidic devices combining the actions of fluid flow and gravity force, 20"
whereby cell trapping can be controlled modulating flow rate, cell density and seeding time (Fu et 21"
al. 2014; Patra et al. 2013). Alternatively, multiple cell spheroids can be generated using hanging 22"
drop plates which rely on gravity-enforced cell assembly (Cavnar et al. 2014; Tung et al. 2011). 23"
This method has been recently combined with the bioprinting approach to generate uniform-sized 24"
embryoid body replacing manual pipetting with the automated printing of single cells and 25"
exploiting the gravity force to induce cell assembly (Xu et al. 2011). All these methods represent 26"
18 
have advantages and disadvantages and require a preliminary optimization phase, which is more or 1"
less extensive depending on the easiness of the system. Anyhow, the growing body of literature in 2"
this field is a clear indication of the wide number of applications whereby cell spheroids can be 3"
used both as 3D models or as tissue building blocks. 4"
In the second part of the study, we applied the same rapid prototyping techniques to produce a 5"
multi-well implantable fibrin construct. Considering the field of cartilage tissue engineering, we 6"
suggest that a similar configuration can be used to generate high cell density areas within the 7"
construct, leading to the formation of “chondrogenic centers” able to promote the differentiation of 8"
low cell density regions. Indeed, it has been shown that cell density affects the capability of 9"
chondrocytes to produce specific matrix and that a high cell density improves cartilaginous matrix 10"
deposition in 3D scaffolds (Mauck et al. 2003; Talukdar et al. 2011). Since cartilage biopsies 11"
harvestable from patients are limited in size and allow the retrieval of a limited number of 12"
chondrocytes, an extensive in vitro expansion phase is required to obtain enough cells to seed a 3D 13"
scaffold with a high cell density, which implies chondrocyte de-differentiation (Giannoni and 14"
Cancedda 2006; Giannoni et al. 2005; Schulze-Tanzil 2009; Steinert et al. 2007). The possibility of 15"
limiting the high cell density to some construct regions, acting as “chondrogenic centers”, implies a 16"
reduction in the number of cells required to seed the construct, and subsequently a shorter 17"
expansion phase and a lower impact of cell de-differentiation. Similar approaches have been 18"
proposed by other groups that have used chondrocytes aggregates of different dimensions seeded 19"
either in a collagen porous scaffold (Wolf et al. 2008) or embedded in a hydrogel (Moreira Teixeira 20"
et al. 2012). Here, we did not generate the chondrocyte aggregate before, but high cell density 21"
centers were represented by confluent cell multilayers within the wells. We found that 3D culture in 22"
fibrin constructs supported the chondrogenic re-differentiation of articular chondrocytes, as 23"
demonstrated by gene expression analysis over time. Furthermore, we found that the presence of 24"
high cell density regions in the fibrin constructs improved the transcriptional expression of 25"
chondrogenic markers such as SOX9 and ACAN, which encode respectively for a transcriptional 26"
19 
factor modulating the chondrogenic cascade and for one of the major components of cartilaginous 1"
extracellular matrix, supporting the hypothesis that high cell density regions may act as 2"
chondrogenic centers; however, the short period of in vitro culture did not allow us to appreciate 3"
possible differences in terms of extracellular matrix deposition. 4"
Remarkably, the construct configurations proposed here also offer the flexibility to be seeded with 5"
pre-formed cell aggregates where desired, being the dimensions of the wells compatible with those 6"
of chondrocyte spheroids obtained through standard techniques (1.5x105-5x105 cells/spheroid). In 7"
this case, the use of multi-well constructs described here would allow the controlled distribution of 8"
cell aggregates which cannot be achieved through a randomized seeding.  9"
As hypothesized for the PDMS chips, the multi-well construct produced in this study, can be used 10"
for the co-culture of different cell types that is usually performed by more standard 3D models such 11"
as spheroids (Giovannini et al. 2010; Lopa et al. 2013; Wu et al. 2012) and random cell dispersion 12"
in 3D scaffolds (Hildner et al. 2009; Sabatino et al. 2012). The controlled distribution of 13"
mesenchymal stem cells and bovine chondrocytes in an implantable multi-well scaffold has been 14"
performed in a recent study screening the effect of several extracellular matrix components on the 15"
chondrogenesis of MSCs co-cultured with bovine chondrocytes (Higuera et al. 2013). Differently 16"
from this screening platform where a polymeric scaffold is used and cells are seeded uniquely into 17"
the wells (Higuera et al. 2013), in our fibrin multi-well construct cells can be seeded both into the 18"
construct structure and in the wells, further allowing to evaluate the interactions among multiple 19"
cell types distributed in different construct regions.  20"
Bioprinting techniques could be exploited as an alternative to the biofabrication approach employed 21"
here to control cell distribution in 3D fibrin constructs, as reported in a recent study where human 22"
endothelial cells and fibrin have been used as bio-ink for microvasculature construction (Cui and 23"
Boland 2009). Similarly to the biofabrication method that we have used in the present study, the 24"
bioprinting approach would be suitable for the generation of constructs seeded with multiple cell 25"
types (Kolesky et al. 2014; Schuurman et al. 2011). As demonstrated by several studies employing 26"
20 
bioprinting to generate complex 3D structures, this approach allows a precise control over construct 1"
configuration and cell distribution (Murphy and Atala 2014). However, differently from the easy 2"
biofabrication method that we have presented here, the implementation of bioprinting would require 3"
an extensive preliminary phase to establish the optimal concentration of fibrinogen, thrombin, 4"
CaCl2 as well as the polymerization time to obtain the desired configuration and grant proper cell 5"
distribution and viability, representing a highly time-consuming phase in the biofabrication process.  6"
Regarding the behavior of fibrin constructs in vivo, we observed a dramatic size reduction of the 7"
implants after 5 weeks of subcutaneous implantation. This result has been previously reported in 8"
several short-term in vivo studies (Colombini et al. 2014b; Hwang et al. 2013; Peretti et al. 2000) 9"
and can be explained by two major features of fibrin: its tendency to shrink and its fast degradation 10"
rate (Ahmed et al. 2008; Meinhart et al. 1999; Wolbank et al. 2014). Thanks to fluorescent cell 11"
staining, we verified that the implant size reduction did not alter cell distribution. Indeed dispersed 12"
red-stained cells and green-stained spot corresponding to the high cell density regions were clearly 13"
visible before and after subcutaneous implantation. On the other hand, when fibrin constructs were 14"
cultured in vitro for 7 days we observed a poor construct remodeling, meaning that the multi-well 15"
structure was well preserved and that cells were not able to deposit a relevant amount of 16"
extracellular matrix. These observations can be explained by the short period of in vitro culture 17"
applied, sufficient to reveal an increase in the transcriptional expression of chondrogenic genes, but 18"
not a relevant deposition of matrix proteins, and by the high concentration of fibrinogen used in our 19"
fibrin glue formulation, further stabilized by the presence of aprotinin (Meinhart et al. 1999). 20"
Hence, since it has been shown that lower concentrations of fibrinogen are compatible with the 21"
biofabrication of patterned scaffolds (Koroleva et al. 2012), we envision to tune this parameter in 22"
future in vitro studies in order to favor the interaction of multiple cell types seeded in different 23"
construct regions as well as extracellular matrix deposition. 24"
 25"
21 
Conclusions 1"
We have presented a cost-effective method exploitable for the fabrication of platforms for the 2"
culture of multiple cell spheroids and for scaffold prototyping. Remarkably, the proposed 3"
fabrication approach is simple and exploits economic tools, as commercial design software and 4"
desktop laser, which do not require dedicated facilities and are accessible to most research labs. 5"
These features prompting the application of this approach in basic and translational research, 6"
whereby cell spheroids and 3D constructs represent key models in drug screening studies as well as 7"
the building blocks for translational tissue engineering approaches.  8"
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List of Figures: 1"
Figure 1. Fabrication of PDMS multi-well chips for cell spheroid generation and culture. (a) 2"
Laser-ablated PMMA molds (I) were used to generate the multi-well PDMS chips (II). PDMS chips 3"
were placed in a 12 well multiwell plate, cells were seeded in the wells and the multiplate was 4"
centrifuged to promote spheroid formation (III). Then, medium was added and PDMS chips were 5"
maintained in culture for 21 days (IV). (b) CAD drawing including top view with insets showing 6"
diameters, pitch, height of the wells and taper angle. Corresponding values for the two 7"
configurations (Chip A, Chip B) are indicated in table. (c) 3D rendering of Chip A and Chip B. (d) 8"
Optical images of chip A (Øwell 2 mm) and chip B (Øwell 3.4 mm) fabricated by PDMS replica 9"
molding on the corresponding PMMA master-templates (scale bars 1 mm, except where noted).  10"
 11"
Figure 2. Biofabrication of implantable multi-well fibrin constructs. (a) Laser-ablated PMMA 12"
molds (I) were used to generate PDMS counter-molds (II). Cells were mixed with fibrinogen and 13"
thrombin and poured into the PDMS mold to generate the multi-well bottom layer (III). After 14"
polymerization, the bottom layer was removed from the PDMS mold and cells were seeded in the 15"
wells of the construct (IV). A top layer made from cell-loaded fibrin was poured over the bottom 16"
layer to ultimate the scaffold (V). Medium was added for construct culture (VI). (b) CAD drawing 17"
including top view with insets showing diameters, pitch and height of the pillars. Corresponding 18"
values for the three mold configurations (Mold X, Mold Y, Mold Z) are indicated in table. (c) 3D 19"
rendering of the three PDMS mold configurations. (d) Top view of the three different bottom layer 20"
configurations of PMMA master templates and PDMS molds fabricated by laser ablation and 21"
replica molding, respectively (scale bars 5 mm). 22"
 23"
Figure 3. Validation of PDMS chips for formation and culture of cell spheroids. (a) Scan of a 24"
12 well multiwell plate containing PDMS multi-well chips after cell seeding (scale bar 10 mm). (b-25"
c) Measurements of time required to perform cell seeding and medium refresh. (d) Micrographs of a 26"
26 
representative well of chip A and chip B at different time points after cell seeding (4 hours, 24 1"
hours, 21 days, scale bar 1 mm). (e) Average area of spheroids cultured in Chip A and Chip B over 2"
time (n=54, data obtained from 3 independent chips both for configuration A and B). (f-h) 3"
Metabolic activity, DNA content, and metabolic activity normalized on DNA measured in spheroids 4"
cultured for 21 days in standard conditions (n=9) or in PDMS chips (n=9, 9 samples harvested from 5"
3 independent chips both for configuration A and B). (i-j) Histological evaluation of GAGs and 6"
type II collagen deposition in spheroids cultured for 21 days in standard conditions and in PDMS 7"
chips (scale bars 200 µm). 8"
 9"
Figure 4. Fabrication of multi-well fibrin constructs and evaluation of cell distribution. (a) 10"
Design and stereomicroscope micrographs showing the three different bottom layer configurations 11"
(scale bars 1 mm). (b) Micrographs showing cell distribution in the multi-well fibrin constructs. 12"
Green-stained cells are embedded into the bottom layer, whereas red-stained cells are seeded into 13"
the wells (scale bar 1 mm). (c) Micrographs showing the central section of a cell-seeded fibrin 14"
constructs (Øwell 1.5 mm, h 1.5 mm, phase contrast and fluorescence microscopy, scale bar 1 mm). 15"
(d) Micrographs showing the multi-well pattern in the construct after the top layer polymerization. 16"
Green-stained cells are embedded into bottom and top layer and red-stained cells are seeded into the 17"
wells (scale bar 1 mm). 18"
 19"
Figure 5. Comparison between fibrin constructs without and with wells. (a) Representative 20"
pictures of fibrin constructs w/o wells and w/ wells (scale bar 2 mm). (b) Micrographs showing cell 21"
distribution in fibrin constructs w/o wells and w/ wells (scale bar 2 mm). (c) Hematoxylin/eosin 22"
staining of construct sections. The border of the well is indicated by a dotted line and cells 23"
distributed along the lower border of the well are indicated by arrows (scale bar 200 µm). (d-e) 24"
DNA content and GAGs content normalized on DNA measured in fibrin constructs w/ and w/o 25"
wells after 7 days of in vitro culture (n=3). (f-i) Transcriptional levels of SOX9, COL2A1, ACAN, 26"
27 
and COMP evaluated in fibrin constructs w/ and w/o wells after 1 and 7 days of in vitro culture 1"
(n=4). Gene expression data are normalized on GAPDH using the delta Ct (dCt) method. 2"
 3"
Figure 6. Cell distribution and GAGs content after in vivo implantation in nude mice. (a) 4"
Micrographs showing fibrin constructs w/o and w/ wells seeded with red and/or green stained cells 5"
prior and after subcutaneous implantation in nude mice (scale bar 1 mm). (b) GAGs content 6"
normalized on construct wet weight measured in fibrin constructs w/o and w/ wells prior and after 7"
subcutaneous implantation.  8"
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